BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang W, Wu YE, Yang XY, Shi J, van den Anker J, Song LL, Zhao W. Oral drugs used to treat persistent pulmonary hypertension of the newborn. Expert Rev Clin Pharmacol 2020;13:1295-308. [PMID: 33180564 DOI: 10.1080/17512433.2020.1850257] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Xie WJ, Zhang S, Su L, Li YH, Zhang X, Ran YG. The efficacy and safety of lenvatinib in the treatment of solid tumors: an up-to-date meta-analysis. Future Oncol 2021;17:745-54. [PMID: 33401983 DOI: 10.2217/fon-2020-0327] [Reference Citation Analysis]
2 Cappagli V, Moriconi D, Bonadio AG, Giannese D, La Manna G, Egidi MF, Comai G, Vischini G, Bottici V, Elisei R, Viola D. Proteinuria is a late-onset adverse event in patients treated with cabozantinib. J Endocrinol Invest. 2021;44:95-103. [PMID: 32363491 DOI: 10.1007/s40618-020-01272-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]